#SCIRecovery
LightNews LightNews
newsmedical.bsky.social
Hypothalamic deep brain stimulation restores walking after spinal cord injury 🚶‍♂️🧠🔬 www.news-medical.net/news/2024120... #SCIRecovery #Neuroscience #WalkingAbility #BrainStimulation #Medical #SpinalCordInjury #HealthTech #NeuroEngineering
Hypothalamic deep brain stimulation restores walking after spinal cord injury
Scientists have identified neurons in the lateral hypothalamus that can be targeted through deep brain stimulation to improve walking after spinal cord injury (SCI). This innovative approach shows pro...
www.news-medical.net
December 3, 2024 at 2:11 AM
stepsrehab.bsky.social
At STEPS Rehabilitation, we deliver expert, research-led care for individuals with spinal cord injuries, helping them achieve the best possible outcomes.

https://stepsrehabilitation.co.uk/medical-conditions/spinal-cord-injuries/

#SpinalCordInjury #Rehabilitation #SCIRecovery #STEPSRehabilitation
January 24, 2025 at 9:00 AM
u2fp.bsky.social
The Twin Cities Marathon is Sold Out BUT - you can still grab a spot in this year’s race by joining Team U2FP for the marathon or 10-mile races. Just email marathon@u2fp.org with your interest and we’ll get you signed up!

#scifundraising #sciadvocacy #scirecovery #marathon
August 27, 2026 at 12:10 AM
u2fp.bsky.social
Headline Patrol: Brain Computer Interfaces Lead to Movement, Sensation & Commercialization?

Link: u2fp.org/get-educated...

#scirecovery #scirehabilitation #scistudies #scitrials #scitechnology
August 30, 2026 at 7:09 PM
u2fp.bsky.social
Tell the FDA what your priorities are - register (it’s free) for the SCI Patient-Focused Drug Development virtual meeting, happening September 29!

Link: www.scipfdd.org/register

#scirecovery #scifunding #scicommunity #sciresearch #scirehabilitation
August 20, 2026 at 9:37 PM
u2fp.bsky.social
Help us guide sci drug development at FDA...sign up for an informational webinar this Wed Aug 5 to learn more.

Link: www.scipfdd.org/webinar

#sciresearch #sciawareness #scirecovery #scirehabilitation #sciadvocacy
August 4, 2026 at 6:00 PM
u2fp.bsky.social
2026 Symposium Videos Available!

Link: u2fp.org/get-educated...

#scirecovery #scisymposium #scirehabilitation
#sci #sciadvocacy
April 2, 2026 at 1:50 AM
u2fp.bsky.social
A new study out from Samuel Stupp got the Headline Patrol treatment by U2FP’s Sam Maddox.

Link for full article: u2fp.org/get-educated...

#sci #sciresearch #scirecovery #scitreatments #scirehabilitation
March 20, 2026 at 7:39 PM
u2fp.bsky.social
U2FP’s 20th Annual Science & Advocacy Symposium. Register now to join us on February 15-17 in Washington, D.C.!

Link to register: secure.qgiv.com/for/2026annu...

#symposium #sci #sciresearch #scirecovery #scirehabilitation
January 22, 2026 at 1:42 AM
u2fp.bsky.social
U2FP’s veteran SCI journalist, Sam Maddox, provides details on this BCI story out of China - including comparison studies along with relevant context, links and solid insight.

Link: u2fp.org/get-educated...

#scirecovery #scireseaech #scitrials #scistudies #scirehabilitation
September 25, 2025 at 7:59 PM
freedomwares.bsky.social
Cannabidiol/tetrahydrocannabinol-enrich extract decreases neuroinfalmmation and improves locomotor outcome following spinal cord injury - tinyurl.com/zah9ydpz

#SpinalCordInjury(#SCI) #Neuroprotection #Cannabinoids #CannabisTherapy #NeuroScience #FunctionalRecovery #CBDTHCExtract #SCIRecovery
Cannabidiol/tetrahydrocannabinol-enrich extract decreases neuroinfalmmation and improves locomotor outcome following spinal cord injury Neuroinflammation is one of the main players in lesion expansion and locomotor deficits after spinal cord injury (SCI), thus treatments to control the inflammatory process emerge as novel therapeutic strategies. In this context, the anti-inflammatory effects of tetrahydrocannabinol (THC) and cannabidiol (CBD), the main phytocannabinoids of Cannabis sativa, are increasingly recognized. The aim of this work was to investigate the effects of a standardized Cannabis sativa extract (CSE), which is mainly composed by THC/CBD in equimolar concentration, on neuroinflammation, secondary damage and locomotor outcome after SCI in rats. After acute SCI, CSE therapy increased the number of non-inflammatory (arginase-1 positive) microglial cells in the epicenter of the lesion and decreased the number of pro-inflammatory ones (arginase-1 negative) in the epicenter and in the rostral and caudal regions of the lesion. CSE also reduced the number of reactive astrocytes in the grey matter of the rostral and caudal regions. These results are consistent with the downregulation of mRNAs of inflammatory mediators (IL-1β, TNFα, IL-6, C3) and the upregulation of anti-inflammatory markers (ARG-1, MRC). In the chronic phase, CSE treatment prevented cyst expansion and also increased the volume of spared grey and white matter. Regarding locomotor outcome, CSE-treated rats showed better locomotor scores (open field test), higher latency to fall (Rotarod test) and lower number of hindlimb foot misplacements (horizontal ladder walking test) than untreated injured rats. These results suggest that this standardized CSE offers a promising perspective for reducing acute neuroinflammation and promoting functional recovery after SCI.
March 31, 2025 at 6:56 PM